(Total Views: 479)
Posted On: 10/22/2020 8:39:52 PM
Post# of 154140
Hopefully CYDY’s latest hire can make some sense of this. From his LinkedIn profile it appears he’s been down this road before. It’d be very interesting to hear his take on it, Maybe a CC is in order?
Anyway it looks like CYDY might have to make a decision soon on which path to take.
1. Continue on the current heading, get enrollment to 293/390 and hope for fair treatment on overwhelmingly good data?
2. Forget about US approval for now. Unblind the data and go for other countries?
3. Forgot about CV altogether. Pursue other indications that are less likely to be politically influenced?
Any other possibilities?
Anyway it looks like CYDY might have to make a decision soon on which path to take.
1. Continue on the current heading, get enrollment to 293/390 and hope for fair treatment on overwhelmingly good data?
2. Forget about US approval for now. Unblind the data and go for other countries?
3. Forgot about CV altogether. Pursue other indications that are less likely to be politically influenced?
Any other possibilities?
(0)
(1)
